Algorae Pharmaceuticals (ASX:1AI) Institutional Ownership: 2.89% (As of Jul. 04, 2026)


What is Algorae Pharmaceuticals Institutional Ownership?

Algorae Pharmaceuticals ASX:1AI +12.50% Institutional Ownership is 2.89% as of Jul. 04, 2026. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Algorae Pharmaceuticals's institutional ownership is 2.89%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Algorae Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Algorae Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.

Algorae Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Algorae Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Algorae Pharmaceuticals Institutional Ownership Chart

Algorae Pharmaceuticals Historical Data

The historical data trend for Algorae Pharmaceuticals can be seen below:

2020-08-31 2020-09-30 2020-10-31 2020-11-30 2020-12-31 2021-01-31 2021-02-28 2021-03-31 2021-04-30 2021-05-31
Institutional Ownership 4.32 4.32 4.34 4.35 4.37 4.40 3.09 2.87 2.88 2.89

Algorae Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 2.89% mean?
Algorae Pharmaceuticals (ASX:1AI) has a Institutional Ownership of 2.89% as of Jul. 04, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Algorae Pharmaceuticals and its competitors.
Is Algorae Pharmaceuticals' Institutional Ownership too high?
Algorae Pharmaceuticals' current Institutional Ownership is 2.89%.
How does Algorae Pharmaceuticals' Institutional Ownership compare to VRTX and REGN?
Algorae Pharmaceuticals' Institutional Ownership of 2.89% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Algorae Pharmaceuticals and its competitors. Algorae Pharmaceuticals's current Institutional Ownership is 2.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Algorae Pharmaceuticals stock overvalued right now?
Algorae Pharmaceuticals (ASX:1AI) has a current Institutional Ownership of 2.89%. The current Institutional Ownership is 2.89%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Algorae Pharmaceuticals (ASX:1AI), the current Institutional Ownership is 2.89% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Algorae Pharmaceuticals Business Description

Other Exchanges LVCLF:USALHI0:Germany
Address 525 Collins Street, Level 23, Rialto South Tower, Melbourne, VIC, AUS, 3000
Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for under met medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. The products of the company comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The company is conceptualized to be a potential treatment for dementia, including Alzheimer's disease, NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.